Literature DB >> 27534739

Effect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging mice.

Claudia Agabiti-Rosei1, Gaia Favero2, Carolina De Ciuceis1, Claudia Rossini1, Enzo Porteri1, Luigi Fabrizio Rodella2, Lorenzo Franceschetti2, Anna Maria Sarkar1, Enrico Agabiti-Rosei1, Damiano Rizzoni1,3, Rita Rezzani2.   

Abstract

Some reports have suggested that inflammation in perivascular adipose tissue (PVAT) may be implicated in vascular dysfunction by causing the disappearance of an anticontractile effect. The aim of this study was to investigate the effects of chronic melatonin treatment on the functional responses of the small mesenteric arteries and on the expression of markers of inflammation/oxidative stress in the aortas of senescence-accelerated prone mice (SAMP8), a model of age-related vascular dysfunction. We investigated seven SAMP8 and seven control senescence-accelerated resistant mice (SAMR1) treated for 10 months with melatonin, as well as equal numbers of age-matched untreated SAMP8 and SAMR1. The mesenteric small resistance arteries were dissected and mounted on a wire myograph, and the concentration-response to norepinephrine was evaluated in vessels with intact PVAT and after the removal of the PVAT. The expression of markers of oxidative stress, inflammation and aging in the aortas was evaluated by immunostaining. In addition, the adiponectin content and the expression of adiponectin receptor 1 were evaluated in the visceral adipose tissue. In untreated SAMP8 mice, we observed an overexpression of oxidative stress and inflammatory markers in the vasculature compared with the controls. No anticontractile effect of the PVAT was observed in untreated SAMP8 mice. Long-term treatment of SAMP8 mice with melatonin increased the expression of some markers of vasoprotection, decreased oxidative stress and inflammation and restored the anticontractile effect of the PVAT. Decreased expression of adiponectin and adiponectin receptor 1 was also observed in visceral fat of untreated SAMP8, whereas a significant increase was observed after melatonin treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27534739     DOI: 10.1038/hr.2016.103

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  69 in total

1.  Vascular hypertrophy and remodeling in secondary hypertension.

Authors:  D Rizzoni; E Porteri; M Castellano; G Bettoni; M L Muiesan; P Muiesan; S M Giulini; E Agabiti-Rosei
Journal:  Hypertension       Date:  1996-11       Impact factor: 10.190

2.  Anticontractile activity of perivascular fat in obese mice and the effect of long-term treatment with melatonin.

Authors:  Claudia Agabiti-Rosei; Carolina De Ciuceis; Claudia Rossini; Enzo Porteri; Luigi F Rodella; Sarah B Withers; Anthony M Heagerty; Gaia Favero; Enrico Agabiti-Rosei; Damiano Rizzoni; Rita Rezzani
Journal:  J Hypertens       Date:  2014-06       Impact factor: 4.844

3.  Relationship between melatonin secretion and nighttime blood pressure in elderly individuals with and without antihypertensive treatment: a cross-sectional study of the HEIJO-KYO cohort.

Authors:  Kenji Obayashi; Keigo Saeki; Nobuhiro Tone; Norio Kurumatani
Journal:  Hypertens Res       Date:  2014-05-22       Impact factor: 3.872

4.  TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase.

Authors:  Tadaaki Nakashima; Seiji Umemoto; Koichi Yoshimura; Susumu Matsuda; Shinichi Itoh; Tomoaki Murata; Tohru Fukai; Masunori Matsuzaki
Journal:  Hypertens Res       Date:  2015-04-09       Impact factor: 3.872

Review 5.  Management and design of the maintenance of SAM mouse strains: an animal model for accelerated senescence and age-associated disorders.

Authors:  M Hosokawa; T Abe; K Higuchi; K Shimakawa; Y Omori; T Matsushita; K Kogishi; E Deguchi; Y Kishimoto; K Yasuoka; T Takeda
Journal:  Exp Gerontol       Date:  1997 Jan-Apr       Impact factor: 4.032

6.  Waist circumference and abdominal adipose tissue distribution: influence of age and sex.

Authors:  Jennifer L Kuk; SoJung Lee; Steven B Heymsfield; Robert Ross
Journal:  Am J Clin Nutr       Date:  2005-06       Impact factor: 7.045

Review 7.  The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon
Journal:  Exp Gerontol       Date:  2005-07-18       Impact factor: 4.032

Review 8.  Current therapies and investigational drugs for peripheral arterial disease.

Authors:  Jun-Ichi Suzuki; Munehisa Shimamura; Hiroyuki Suda; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Mitsuaki Isobe; Issei Komuro; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

9.  Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers.

Authors:  M J Mulvany; O K Hansen; C Aalkjaer
Journal:  Circ Res       Date:  1978-12       Impact factor: 17.367

Review 10.  Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries.

Authors:  Mingyi Wang; Ajay M Shah
Journal:  J Mol Cell Cardiol       Date:  2015-02-07       Impact factor: 5.000

View more
  18 in total

Review 1.  Modulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT).

Authors:  Claudia Agabiti-Rosei; Anna Paini; Carolina De Ciuceis; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Damiano Rizzoni
Journal:  Curr Hypertens Rep       Date:  2018-05-07       Impact factor: 5.369

2.  Ghrelin-mediated pathway in Apolipoprotein-E deficient mice: a survival system.

Authors:  Rita Rezzani; Caterina Franco; Gaia Favero; Luigi F Rodella
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 3.  Vascular Aging in Rodent Models: Contrasting Mechanisms Driving the Female and Male Vascular Senescence.

Authors:  Paula R Barros; Tiago J Costa; Eliana H Akamine; Rita C Tostes
Journal:  Front Aging       Date:  2021-09-08

4.  Renal perivascular adipose tissue: Form and function.

Authors:  Carolina Baraldi A Restini; Alex Ismail; Ramya K Kumar; Robert Burnett; Hannah Garver; Gregory D Fink; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2018-02-15       Impact factor: 5.773

Review 5.  Pro-contractile effects of perivascular fat in health and disease.

Authors:  J G Ramirez; E J O'Malley; W S V Ho
Journal:  Br J Pharmacol       Date:  2017-04-03       Impact factor: 8.739

6.  Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats.

Authors:  Gaia Favero; Valentina Trapletti; Francesca Bonomini; Alessandra Stacchiotti; Antonio Lavazza; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

Review 7.  Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications.

Authors:  Seyed Majid Mousavi Movahhed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-06-07       Impact factor: 3.000

8.  Decrease of Perivascular Adipose Tissue Browning Is Associated With Vascular Dysfunction in Spontaneous Hypertensive Rats During Aging.

Authors:  Ling-Ran Kong; Yan-Ping Zhou; Dong-Rui Chen; Cheng-Chao Ruan; Ping-Jin Gao
Journal:  Front Physiol       Date:  2018-04-18       Impact factor: 4.566

Review 9.  Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?

Authors:  Zukiswa Jiki; Sandrine Lecour; Frederic Nduhirabandi
Journal:  Front Physiol       Date:  2018-05-17       Impact factor: 4.566

Review 10.  Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation.

Authors:  Gaia Favero; Lorenzo Franceschetti; Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Int J Endocrinol       Date:  2017-10-01       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.